We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Consider ‘Net-Benefits’ In Product Lifecycles, CRO Urges Regulators
Consider ‘Net-Benefits’ In Product Lifecycles, CRO Urges Regulators
The FDA should stop thinking just about benefits and risks in a product’s lifecycle and adopt a “net-benefits” approach, a contract research organization has urged the agency.